Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Allergy, Drug

lenalidomide has been researched along with Allergy, Drug in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Beyaz, S; Buyukozturk, S; Colakoglu, B; Coskun, R; Demir, N; Demir, S; Gelincik, A; Kalayoglu-Besisik, S; Nalcacı, M; Ozkan, G; Paksoy, N1
Ballesteros, M; Noguerado-Mellado, B; Rojas-Pérez-Ezquerra, PD; Tornero Molina, P; Zubeldia Ortuño, JM1
Cabañas, R; Castellar PharmG, FR; Dominguez-Ortega, J; Fiandor, A; Gonzalez-Muñoz, M; Heredia, R; Lazzarato, I; López de la Guía, A1
Castells, M; Fanning, L; Laubach, J; Lee, MJ; Richardson, P; Schlossman, R; Wickner, P1
Einsele, H; Kortuem, M1
Feilchenfeldt, J; Györik, S; Lerch, E; Mazzucchelli, L; Quadri, F1
Banglawala, S; Lentz, EM; Reece, DE; Seki, JT1
Davis-Lorton, M; Hindenburg, A; Kujawa, J; Phillips, J1

Other Studies

8 other study(ies) available for lenalidomide and Allergy, Drug

ArticleYear
A practical 16-day desensitization protocol in lenalidomide-induced non-immediate hypersensitivity reactions.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2019, Volume: 123, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Aged; Desensitization, Immunologic; Drug Hypersensitivity; Eczema; Exanthema; Female; Humans; Lenalidomide; Male; Middle Aged; Parapsoriasis; Urticaria

2019
Delayed Hypersensitivity Reaction to Lenalidomide: 2 Different Clinical Patterns in the Same Patient.
    Journal of investigational allergology & clinical immunology, 2019, Volume: 29, Issue:4

    Topics: Aged; Drug Hypersensitivity; Humans; Hypersensitivity, Delayed; Immunologic Factors; Lenalidomide; Male; Phenotype; Skin Tests

2019
Successful desensitization procedure to lenalidomide in a patient with delayed hypersensitivity confirmed with a positive LTT.
    European annals of allergy and clinical immunology, 2020, Volume: 52, Issue:5

    Topics: Aged; Allergens; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Hypersensitivity, Delayed; Immunologic Tests; Lenalidomide; Lymphocyte Activation; Male; T-Lymphocytes; Treatment Outcome

2020
Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma.
    British journal of haematology, 2014, Volume: 167, Issue:1

    Topics: Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Thalidomide; Treatment Outcome

2014
Lenalidomide-induced hypersensitivity pneumonitis.
    Onkologie, 2010, Volume: 33, Issue:5

    Topics: Adrenal Cortex Hormones; Aged; Alveolitis, Extrinsic Allergic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Immunosuppressive Agents; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Recurrence; Thalidomide

2010
A case of lenalidomide-induced hypersensitivity pneumonitis.
    Onkologie, 2010, Volume: 33, Issue:5

    Topics: Aged; Alveolitis, Extrinsic Allergic; Antineoplastic Agents; Diagnosis, Differential; Drug Hypersensitivity; Humans; Lenalidomide; Lung; Male; Multiple Myeloma; Thalidomide; Tomography, X-Ray Computed

2010
Desensitization to lenalidomide in a patient with relapsed multiple myeloma.
    Clinical lymphoma, myeloma & leukemia, 2013, Volume: 13, Issue:2

    Topics: Antineoplastic Agents; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Recurrence; Thalidomide; Treatment Outcome

2013
Successful desensitization in a patient with lenalidomide hypersensitivity.
    American journal of hematology, 2007, Volume: 82, Issue:11

    Topics: Adult; Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Lenalidomide; Multiple Myeloma; Thalidomide

2007